Pathogenesis of neointima formation following vascular injury.
about
Decellularized matrices for cardiovascular tissue engineeringMicroRNA-365 inhibits vascular smooth muscle cell proliferation through targeting cyclin D1Inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models.Interferon regulatory factor 9 is critical for neointima formation following vascular injuryTransglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation.Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model.Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14.Bone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury.Smooth muscle cell-specific Tgfbr1 deficiency attenuates neointimal hyperplasia but promotes an undesired vascular phenotype for injured arteries.Vascular CaMKII: heart and brain in your arteries.Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.Effect of the P2Y12 antagonist ticagrelor on neointimal hyperplasia in a rabbit carotid anastomosis model†.Multifunctional copolymer coating of polyethylene glycol, glycidyl methacrylate, and REDV to enhance the selectivity of endothelial cells.Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis.Cardiovascular stents: overview, evolution, and next generation
P2860
Q27011803-BA0C6B09-80EC-40D6-AD87-8E777C01EB3FQ33754673-B6A801CC-0F1B-47FA-BB41-AAC6E7E71235Q34292314-7E7EAA9C-2F1E-4368-9FF2-C1B72F372D76Q34446578-7C96FE54-B7A5-46ED-813A-CF481F1A6994Q35053942-05BD9B87-A93B-44D0-98C0-F5309ABA88AEQ35070759-D141FAF7-BC35-4FEC-8F8C-711EC3F6C342Q35703384-00F0416E-3B60-4081-B49E-2A8CC27C9C09Q36367490-88FDA62A-E86E-4F2C-933C-FFEA3FBEEEF3Q36583492-7818DB86-BB88-4C2B-9308-B5641DF4EC23Q37328461-3F76BD4F-F06B-4231-A722-21AC20511B3EQ37710674-DDEB19D6-5823-4C51-BD8D-70690717B407Q38866040-07D4C74E-D688-446D-BCB6-13B1823E591DQ42373725-63A6BB69-8B59-4122-874F-DADF71C665E9Q47864690-041019C1-C532-466E-B369-93CF06F2BB90Q51716517-6264A7EA-5332-42B5-97BA-27BA2C36EBDAQ55491477-A670D880-0C92-4394-BA4E-694DB87AC6BDQ58752931-82B37204-AD99-45D3-95D4-FFFDBC25B49F
P2860
Pathogenesis of neointima formation following vascular injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis of neointima formation following vascular injury.
@en
Pathogenesis of neointima formation following vascular injury.
@nl
type
label
Pathogenesis of neointima formation following vascular injury.
@en
Pathogenesis of neointima formation following vascular injury.
@nl
prefLabel
Pathogenesis of neointima formation following vascular injury.
@en
Pathogenesis of neointima formation following vascular injury.
@nl
P2093
P1476
Pathogenesis of neointima formation following vascular injury.
@en
P2093
Ali Pourdjabbar
Benjamin Hibbert
Edward R O' Brien
Trevor Simard
P356
10.2174/187152911795945169
P577
2011-03-01T00:00:00Z